We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$323B
AUM Growth
+$11.5B
Cap. Flow
+$13.1B
Cap. Flow %
4.05%
Top 10 Hldgs %
14.39%
Holding
7,731
New
673
Increased
3,224
Reduced
3,031
Closed
497

Sector Composition

Rank Sector Weight
1 Financials 8.41%
2 Healthcare 8.04%
3 Technology 7.66%
4 Energy 6.94%
5 Consumer Discretionary 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARC
5701
DELISTED
ARC Document Solutions, Inc.
ARC
$285K ﹤0.01%
37,484
-20,253
-35% -$165K
PHLT
5702
DELISTED
Performant Healthcare Inc
PHLT
$284K ﹤0.01%
87,795
+65,308
+290% +$203K
BPTH
5703
DELISTED
Bio-Path Holdings Inc
BPTH
$284K ﹤0.01%
62
+55
+786% +$301K
EMD
5704
Western Asset Emerging Markets Debt Fund
EMD
$606M
$283K ﹤0.01%
+18,940
New +$301K
ONCE
5705
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$283K ﹤0.01%
+4,700
New +$311K
MORE
5706
DELISTED
Monogram Residential Trust, Inc.
MORE
$283K ﹤0.01%
31,423
-237,104
-88% -$2.25M
PTX
5707
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$283K ﹤0.01%
4,773
+2,252
+89% +$159K
CKP
5708
DELISTED
CHECKPOINT SYSTEMS INC
CKP
$283K ﹤0.01%
27,843
-11,931
-30% -$126K
PULB
5709
DELISTED
PULASKI FINANCIAL CORP
PULB
$283K ﹤0.01%
21,889
-5,304
-20% -$68K
QMCO icon
5710
Quantum Corp
QMCO
$411M
$282K ﹤0.01%
1,049
+346
+49% +$106K
FCRD
5711
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$282K ﹤0.01%
24,420
-2,018
-8% -$24.7K
IVTY
5712
DELISTED
Invuity, Inc
IVTY
$282K ﹤0.01%
+20,000
New +$291K
ECOL
5713
DELISTED
US Ecology, Inc.
ECOL
$281K ﹤0.01%
5,769
-2,178
-27% -$105K
DBD
5714
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
$280K ﹤0.01%
+8,000
New +$282K
NPTN
5715
DELISTED
NEOPHOTONICS CORP
NPTN
$280K ﹤0.01%
30,625
-8,429
-22% -$63.9K
ARNA
5716
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
$280K ﹤0.01%
6,040
-1,640
-21% -$71.1K
PVG
5717
DELISTED
PRETIUM RESOURCES INC.
PVG
$280K ﹤0.01%
51,782
-6,578
-11% -$38.3K
MZOR
5718
DELISTED
Mazor Robotics Ltd.
MZOR
$280K ﹤0.01%
21,015
-7,613
-27% -$97.5K
RLYP
5719
DELISTED
RELYPSA INC COM
RLYP
$280K ﹤0.01%
8,470
+2,319
+38% +$79.7K
ATAXZ
5720
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$280K ﹤0.01%
50,410
+4,312
+9% +$24K
NRP icon
5721
Natural Resource Partners
NRP
$1.31B
$279K ﹤0.01%
7,355
-23,280
-76% -$1.17M
ZNH
5722
DELISTED
China Southern Airlines Company Limited
ZNH
$279K ﹤0.01%
4,788
-2,010
-30% -$101K
CCS icon
5723
Century Communities
CCS
$1.98B
$278K ﹤0.01%
+13,790
New +$277K
CMF icon
5724
iShares California Muni Bond ETF
CMF
$4.55B
$278K ﹤0.01%
4,818
-138
-3% -$8.03K
NQM
5725
DELISTED
NUVEEN INVESTMENT QLTY MUNI FD
NQM
$278K ﹤0.01%
+19,173
New +$293K

Similar funds

Goldman Sachs's Q2 2015 Portfolio in Review

As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.

By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.

  • Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
  • Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
  • Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
  • Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
  • Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
  • Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
  • Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.